+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Effect of simvastatin on bone turnover and bone density in postmenopausal hypercholesterolemic women A 1-year longitudinal Study



Effect of simvastatin on bone turnover and bone density in postmenopausal hypercholesterolemic women A 1-year longitudinal Study



Journal of Bone & Mineral Research 17(Suppl 1): S484




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034804960

Download citation: RISBibTeXText


Related references

Effect of simvastatin treatment on bone mineral density and bone turnover in hypercholesterolemic postmenopausal women: A 1-year longitudinal study. Bone (New York) 32(4): 427-433, 2003

The effect of high-dose vitamin D on bone mineral density and bone turnover markers in postmenopausal women with low bone mass--a randomized controlled 1-year trial. Osteoporosis International 23(1): 201-211, 2012

Simvastatin increases bone mineral density in hypercholesterolemic postmenopausal women. Metabolism: Clinical and Experimental 53(6): 744-748, 2004

A longitudinal HR-pQCT study of alendronate treatment in postmenopausal women with low bone density: Relations among density, cortical and trabecular microarchitecture, biomechanics, and bone turnover. Journal of Bone and Mineral Research 25(12): 2558-2571, 2010

Longitudinal changes of bone mineral density and bone turnover in postmenopausal women on thyroxine. Clinical Endocrinology. 46(3): 301-307, 1997

Longitudinal changes of bone mineral density and bone turnover in postmenopausal women on thyroxine. Journal of Endocrinology 148(Suppl. ): P183, 1996

Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 81(10): 3487-3491, 1996

Alendronate produces greater effects than raloxifene on bone density and bone turnover in postmenopausal women with low bone density: results of EFFECT (Efficacy of FOSAMAX versus EVISTA Comparison Trial) International. Journal of Internal Medicine 255(4): 503-511, 2004

Denosumab in treatment-naïve and pre-treated with zoledronic acid postmenopausal women with low bone mass: Effect on bone mineral density and bone turnover markers. Metabolism: Clinical and Experimental 64(10): 1291-1297, 2015

Calcium and vitamin D fortified milk reduces bone turnover and improves bone density in postmenopausal women over 1 year. European Journal of Nutrition 57(8): 2785-2794, 2018

Association of bone metabolism related genes polymorphisms with the effect of raloxifene hydrochloride on bone mineral density and bone turnover markers in postmenopausal women with osteoporosis. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 23(2): 129-133, 2006

Effects of raloxifene on bone mineral density and biochemical markers of bone turnover in postmenopausal women with osteoporosis 4-Year results from the MORE trial. Journal of Bone & Mineral Research 15(Suppl 1): S556, 2000

Effects of simvastatin on bone turnover and BMD: a 1-year randomized controlled trial in postmenopausal osteopenic women. Journal of Bone and Mineral Research 19(5): 737-744, 2004

Effect of soybean intake on bone mineral density and bone turnover markers in postmenopausal women. Taehan Kanho Hakhoe Chi 36(6): 933-941, 2006

Effect of Denosumab on Bone Mineral Density and Markers of Bone Turnover among Postmenopausal Women with Osteoporosis. Journal of Osteoporosis 2016: 8738959, 2016